Top Markets
Coin of the day
HLS Therapeutics Inc. HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLS
Pozycja w akcjach #22602
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Cena akcji
$2.75
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$86.08M
Zmiana (1 dzień)
-3.85%
Zmiana (1 rok)
-27.06%
Kraj
CA
Handel HLS Therapeutics Inc. (HLS)

Kategoria

Historia ceny akcji dla HLS Therapeutics Inc. (HLS)
Najwyższa cena zamknięcia: $2.84 dnia 2026-08-01

Najniższa cena zamknięcia: $8.95 dnia 2018-03-01
Historia cen akcji firmy HLS Therapeutics Inc. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -2.35%
2025 38.06%
2024 -5.73%
2023 -63.25%
2022 -36.71%
2021 -13.17%
2020 -7.23%
2019 30.14%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN